Emerging Strategies for the Management of Atherogenic Dyslipidaemia

被引:6
|
作者
Agarwala, Anandita [1 ]
Shapiro, Michael D. [2 ]
机构
[1] Washington Univ, Sch Med, Div Cardiol, St Louis, MO USA
[2] Wake Forest Univ, Baptist Med Ctr, Sect Cardiovasc Med, Ctr Prevent Cardiovasc Dis, Winston Salem, NC 27157 USA
关键词
CARDIOVASCULAR RISK; LIPOPROTEIN(A); ANGPTL3; ANTIBODY; DISEASE;
D O I
10.15420/ecr.2019.16
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:38 / 40
页数:3
相关论文
共 50 条
  • [1] Strategies for the Management of Diabetic Dyslipidaemia
    Marja-Riitta Taskinen
    Drugs, 1999, 58 : 47 - 51
  • [2] Strategies for the management of diabetic dyslipidaemia
    Taskinen, MR
    DRUGS, 1999, 58 (Suppl 1) : 47 - 51
  • [3] Established and Emerging Approaches for the Management of Dyslipidaemia
    Norata, Giuseppe Danilo
    SCIENTIFICA, 2012, 2012
  • [4] Atherogenic Dyslipidaemia 2019. Consensus document of the Atherogenic Dyslipidaemia Group of the Spanish Arteriosclerosis Society
    Ascaso, Juan F.
    Millan, Jesus
    Hernandez-Mijares, Antonio
    Blasco, Mariano
    Brea, Angel
    Diaz, Angel
    Pedro-Botet, Juan
    Pinto, Xavier
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2020, 32 (03): : 120 - 125
  • [5] Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia
    Rizzo, Manfredi
    Rini, Giovam Battista
    ARCHIVES OF MEDICAL SCIENCE, 2011, 7 (01) : 5 - 7
  • [7] Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias
    Pedro-Botet, Juan
    Ascaso, Juan F.
    Blasco, Mariano
    Brea, Angel
    Diaz, Angel
    Hernandez-Mijares, Antonio
    Pinto, Xavier
    Millan, Jesus
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2020, 32 (05): : 209 - 218
  • [8] The role of atherogenic dyslipidaemia in clinical practice guidelines
    Pedro-Botet, Juan
    Mantilla-Morato, Teresa
    Diaz-Rodriguez, Angel
    Brea-Hernando, Angel
    Gonzalez-Santos, Pedro
    Hernandez-Mijares, Antonio
    Pinto, Xavier
    Millan Nunez-Cortes, Jesus
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 (02): : 65 - 70
  • [9] New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
    Lorenzatti, Alberto J.
    Toth, Peter P.
    EUROPEAN CARDIOLOGY REVIEW, 2020, 15 : 29 - 37
  • [10] Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia
    Wierzbicki, Anthony S.
    CURRENT OPINION IN CARDIOLOGY, 2009, 24 (04) : 372 - 379